Fact CheckerSign in

NCT06508541Completed

The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery

The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery: a Retrospective Cohort Study

Source: ClinicalTrials.gov · Last updated 16 Dec 2024

Brief summary (registry, in English)

Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging

Status (registry)
Completed
Study type
Observational
Enrollment
235 (actual)
First submitted
13 Jul 2024
Start date
15 Jul 2024
Primary completion date
1 Oct 2024
Lead sponsor
Shanghai Tong Ren Hospital
NCT number
NCT06508541

What you commit to

  • Study type: Observational
  • Participants enrolled: 235
  • From 15 Jul 2024 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • history of previous colorectal surgery, emergent surgery, or palliative resection;

Other illness

  • allergy or history of an adverse reaction to ICG; and
  • severe mental disorder.

Other

  • pregnancy or breastfeeding;

Who the study is looking for

  • age \> 18 years,
  • confirmed diagnosis of primary CRC,
  • preoperative tumor stage of cT1 to cT4, N-/+, M0 as determined by contrast-enhanced computed tomography (CT),
  • no distant metastasis, -American Society of Anesthesiologists(ASA)Physical Status Classification score of 1, 2, or 3-

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Tongren Hospital
Coordinator of this site? Confirm its status
ChangningChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.